**Core Concept:** The urea cycle is a series of enzymatic reactions that occur in the liver to detoxify ammonia produced as a byproduct of protein breakdown in the brain. The cycle results in the production of urea, which is then transported to the kidneys for excretion. The enzyme ornithine transcarbamylase (OTC) plays a key role in the urea cycle.

**Why the Correct Answer is Right:** Ornithine transcarbamylase (OTC) deficiency is a genetic disorder affecting the urea cycle. In this condition, the enzyme OTC is missing or not functional, leading to impaired ability to detoxify ammonia. As a result, ammonia levels rise in the blood, eventually crossing the blood-brain barrier and accumulating in the brain. This causes brain damage and neurological symptoms, such as seizures, developmental delay, and cognitive impairment.

**Why Each Wrong Option is Incorrect:**

A. Ornithine transcarbamylase (OTC) deficiency is not the only urea cycle disorder causing neurological symptoms. Other enzyme deficiencies, such as arginase deficiency and argininosuccinate synthase deficiency, can also present with similar symptoms. However, they are less common and have different underlying enzymatic defects.

B. Citrullinemia is another disorder, mainly affecting infants, caused by mutations in the genes encoding enzymes of the urea cycle. However, it is distinguished by its presentation in early infancy, rather than later in life as in OTC deficiency.

C. Carbamoyl phosphate synthase 1 (CPS1) deficiency is a different type of urea cycle disorder. While both OTC deficiency and CPS1 deficiency can present with neurological symptoms, they have different enzymatic defects, phenotypes, and treatment approaches.

D. Citrullinemia II, also known as argininosuccinate synthase deficiency, is another urea cycle disorder with neurological symptoms. However, it is distinguished by its presentation in early infancy and distinct enzymatic defect (involving argininosuccinate synthase).

**Clinical Pearl:** Enzyme deficiencies affecting the urea cycle can present with neurological symptoms and developmental delay. These disorders are typically diagnosed in early childhood or infancy, enabling early intervention and management. Familiarity with the different enzyme deficiencies and their presentations can help guide early diagnosis and treatment for affected patients.